An improved synthesis of selectively protected L-Dopa derivatives from L-tyrosine

Journal of Organic Chemistry

Volumn 65, Issue 8, 2000, Pages 2574-2576

  Chen, Chen ^a   Zhu, Yun Fei ^a   Wilcoxen, Keith ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; TYROSINE;

DRUG SYNTHESIS; HEATING; NOTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; REACTION ANALYSIS;

INDICATORS AND REAGENTS; LEVODOPA; OXIDATION-REDUCTION; TYROSINE;

EID: 0034697255     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9913661     Document Type: Note

References (34)

1. (a) Tamai, S.; Kaneda, M.; Nakamura, S. J. Antibiot. 1982, 35, 1130.
2. (b) Kaneda, M.; Tamai, S.; Nakamura, S.; Hirata, T.; Kushi, Y.; Suga, T. J. Antibiot. 1982, 35, 1137.
3. (a) Kase, M.; Kaneko, M.; Yamada, K. J. Antibiot. 1987, 40, 450.
4. (b) Yasuzawa, T.; Shirahata, C.; Sano, H. J. Antibiot. 1987, 40, 455.
5. (a) Sano, S.; Ikai, K.; Katayama, K; Takesako, K.; Nakamura, T.; Obayashi, A.; Ezure, Y.; Enomoto, H. J. Antibiot. 1986, 39, 1685.
6. (b) Sano, S.; Ikai, K.; Kuroda, H.; Nakamura, T.; Obayashi, A.; Ezure, Y.; Enomoto, H. J. Antibiot. 1986, 39, 1674.
7. (c) Sano, S.; Ikai, K.; Yoshikawa, Y.; Nakamura, T.; Obayashi, A. J. Antibiot. 1987, 40, 512.
8. (d) Sano, S.; Kuroda, H.; Ueno, M.; Yoshikawa, Y. Nakamura, T.; Obayashi, A. J. Antibiot. 1987, 40, 519.
9. Jolad, S. D.; Hoffmann, J. J.; Torrance, S. J.; Wiedhopf, R. M.; Cole, J. R.; Arora, S. K.; Bates, R. B.; Gargiuro, R. L.; Krieke, G. R. J. Am. Chem. Soc. 1977, 99, 8040.
10. (a) Review: Itokawa, H.; Takeya, K. Heterocycles 1993, 35, 1467.
11. (b) Ikokawa, H.; Takeya, K.; Mori, N.; Sonobe, T.; Mihashi, S.; Hamanaka, T. Chem. Pharm. Bull. 1986, 34, 3762.
12. (c) Itokawa, H.; Takeya, K.; Mihara, K.; Mori, N.; Hamanaka, T.; Sonobe, T.; Iitaka, Y. Chem. Pharm. Bull. 1983, 31, 1424.
13. (d) Itokawa, H.; Takeya, K.; Mori, N.; Kidohoro, S.; Yamamoto, H. Planta Med. 1984, 51, 313.
14. Boger, D. L.; Yohannes, D. J. Org. Chem. 1987, 52, 5283.
15. (a) Siuda, J. F. J. Org. Chem. 1975, 40, 3611.
16. (b) Banerjee, N.; Ressler, C. J. Org. Chem. 1976, 41, 3056.
17. (c) Kawai, M.; Chorev, M.; Marin-Rose, J.; Goodman, M. J. Med. Chem. 1980, 23, 420.
18. (d) Cohen, T.; Dietz, A. G., Jr.; Miser, J. R. J. Org. Chem. 1977, 42, 2057.
19. (e) Konda, M.; Shioiri, T.; Yamada, S.-i. Chem. Pharm. Bull. 1975, 23, 1063.
20. (f) Bretshneider, H.; Hohenlohe-Oehringen, K.; Kaiser, A.; Wolcke, U. Helv. Chim. Acta 1973, 56, 2857.
21. Jung, M. E.; Lazarova, T. I. J. Org. Chem. 1997, 62, 1553.
22. 6 Selectively protected catechol derivatives of D,L-Dopa have been prepared from isovanillin, see: Wilcox, M. E.; Wyler, H.; Mabry, T. J.; Dreiding, A. S. Helv. Chim. Acta 1965, 48, 252.
23. Boger, D. L.; Coleman, R. S. J. Org. Chem. 1986, 51, 5436. also see ref 7a-e.
24. (a) Schmidt, U.; Weller, D.; Holder, A.; Lieberknecht, A. Tetrahedron Lett. 1988, 29, 3227.
25. (b) Boger, D. L.; Yohnnes, D.; Zhou, J.; Patane, M. A. J. Am. Chem. Soc. 1993, 115, 3420.
26. (c) Boger, D. L.; Yohannes, D. J. Am. Chem. Soc. 1991, 113, 1427.
27. (d) Boger, D. L.; Yohannes, D. J. Org. Chem. 1991, 56, 1763.
28. (e) Boger, D. L.; Yohannes, D.; Meyers, J. B., Jr. J. Org. Chem. 1992, 57, 1319.
29. (f) Boger, D. L.; Yohannes, D. J. Org. Chem. 1989, 54, 2498.
30. (h) Boger, D. L.; Yohannes, D. J. Org. Chem. 1990, 55, 6000.
31. 10 All these methods provide the desired compounds in yield 30% or less.
32. On one millimole scale using peracetic acid (32 wt % in acetic acid, 2 equiv, room temperature, 10 days).
33. a) Erickson, S. D.; Simon, J. A.; Still, W. C. J. Org. Chem. 1993, 58, 1305.
34. (b) Tsuda, Y.; Hosoi, S.; Ishida, K.; Sangai, M. Chem. Pharm. Bull. 1994, 42, 204.